feed,title,long_url,short_url
SeekingAlpha,Replimune climbs on promising Phase 2 data for skin cancer therapy,https://seekingalpha.com/news/3702846,
SeekingAlpha,Mindset Pharma picks psilocybin-based compound MSP-1014 as lead clinical candidate,https://seekingalpha.com/news/3702844,
SeekingAlpha,Take-Two Interactive upgraded at Jefferies on pipeline strength,https://seekingalpha.com/news/3702845,
SeekingAlpha,"Private payrolls gain 978K in May, April gain revised down 88K to 654K",https://seekingalpha.com/news/3702253,
SeekingAlpha,Merck spinoff Organon begins trading on the NYSE today; Merck down 4%,https://seekingalpha.com/news/3702841,
